Epalrestat Market Innovation Driving Treatment Advancements
The Epalrestat Market is witnessing steady growth as the global burden of diabetes and its associated complications continues to rise. Epalrestat is primarily used in the management of diabetic neuropathy by inhibiting the aldose reductase enzyme, helping reduce nerve damage associated with prolonged high blood glucose levels. Growing awareness of diabetes-related complications, increasing...
0 Commenti
0 condivisioni